Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Black Diamond Therapeutics Inc (NQ: BDTX )

3.690 -0.170 (-4.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,194
Open 3.840
Bid (Size) 3.600 (2)
Ask (Size) 3.810 (2)
Prev. Close 3.860
Today's Range 3.680 - 3.840
52wk Range 1.460 - 10.47
Shares Outstanding 36,213,654
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Black Diamond Therapeutic: Q2 Earnings Insights
  Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
$1 Million Bet On CalAmp? 4 Penny Stocks Insiders are Buying
U.S. stocks opened slightly lower on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... 
Via Benzinga

Performance

YTD
-34.22%
-34.22%
1 Month
+12.16%
+12.16%
3 Month
+107.30%
+107.30%
6 Month
N/A
N/A
1 Year
-59.54%
-59.54%

More News

Read More
Black Diamond Therapeutic: Q1 Earnings Insights
Via Benzinga
Executives Buy Around $1.6M Of 4 Penny Stocks
Via Benzinga
Black Diamond Cuts 30% Of Its Workforce, Discontinues Drug From its 'MasterKey' Pipeline
Via Benzinga
Executives Buy Around $5M Of 3 Penny Stocks
Via Benzinga
4 Stocks Under $5 Insiders Are Aggressively Buying
Via Benzinga
53 Biggest Movers From Yesterday
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Black Diamond Therapeutics Stock Is Trading Higher Today
Via Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Via Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Via Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
Via Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Via Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Via Benzinga
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.